The data was revealed on Wednesday by the Russian Direct Investment Fund (RDIF), the sovereign wealth fund which bankrolled the vaccine’s development. Evaluation of the vaccine’s performance is based on analysis of real-world experience obtained in the Republic of San Marino. About 70% of the microstate’s 34,000-strong population have received the …
Read More »
The results of the large-scale research by the Ministry of Health of the City of Buenos Aires were published in the prestigious, peer-reviewed Journal of the American Medical Association (JAMA) last week. The study included more than 660,000 elderly residents of Buenos Aires who had been vaccinated with Sputnik V, AstraZeneca …
Read More »
The results of second-phase trials of the vaccine, known as R21 / Matrix-M and developed by the University of Oxford in cooperation with pharmaceutical giant Novax, were published in Preprints with The Lancet earlier this week. The researchers claim that the immunization has proven effective in a trial that involved …
Read More »
On Monday, the pharmaceutical giant released promising interim results from its US study, which showed its drug to have 79% efficacy in stopping symptomatic Covid-19 and to be 100% effective at preventing severe cases and hospitalization. The firm also said that the results showed that the drug does not cause …
Read More »
The scientists pointed to data from a study published in the Lancet last month that found the British-Swedish vaccine had only 62 percent efficacy, compared with over 90 percent for the Pfizer-BioNTech alternative. A large-scale trial in the UK and Brazil reported a 62 percent effectiveness for those who were …
Read More »
In a statement, Moscow’s Gamaleya Institute and Russian Direct Investment Fund (RDIF), which funded the vaccine’s development, cited data received from volunteers 21 days after they were inoculated with the first dose of the jab. The results confirmed a 91.4 percent efficacy rate overall and showed that it is “100 …
Read More »
On Monday, the pharmacological company announced that its AZD1222 vaccine for Covid-19, which is based on a common cold virus that causes infection in chimpanzees, has an efficacy of 70 percent. The number is average for two slightly different tests. One involved people, who received half a dose of the …
Read More »
The Lancet, the New England Journal of Medicine, and the American Medical Association Journal all turned down the paper, Danish media reported on Thursday. The study, which began in late April, involved 6,000 Danes, half of whom were asked to wear masks at all times in public places. The other …
Read More »